BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

353 related articles for article (PubMed ID: 28600504)

  • 1. Amphiregulin contained in NSCLC-exosomes induces osteoclast differentiation through the activation of EGFR pathway.
    Taverna S; Pucci M; Giallombardo M; Di Bella MA; Santarpia M; Reclusa P; Gil-Bazo I; Rolfo C; Alessandro R
    Sci Rep; 2017 Jun; 7(1):3170. PubMed ID: 28600504
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multiple myeloma-derived exosomes are enriched of amphiregulin (AREG) and activate the epidermal growth factor pathway in the bone microenvironment leading to osteoclastogenesis.
    Raimondo S; Saieva L; Vicario E; Pucci M; Toscani D; Manno M; Raccosta S; Giuliani N; Alessandro R
    J Hematol Oncol; 2019 Jan; 12(1):2. PubMed ID: 30621731
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumour-derived exosomal lncRNA-SOX2OT promotes bone metastasis of non-small cell lung cancer by targeting the miRNA-194-5p/RAC1 signalling axis in osteoclasts.
    Ni J; Zhang X; Li J; Zheng Z; Zhang J; Zhao W; Liu L
    Cell Death Dis; 2021 Jul; 12(7):662. PubMed ID: 34215717
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CXCR4 Accelerates Osteoclastogenesis Induced by Non-Small Cell Lung Carcinoma Cells Through Self-Potentiation and VCAM1 Secretion.
    Liao T; Chen W; Sun J; Zhang Y; Hu X; Yang S; Qiu H; Li S; Chu T
    Cell Physiol Biochem; 2018; 50(3):1084-1099. PubMed ID: 30355915
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reconstitution of amphiregulin-epidermal growth factor receptor signaling in lung squamous cell carcinomas activates PTHrP gene expression and contributes to cancer-mediated diseases of the bone.
    Gilmore JL; Gonterman RM; Menon K; Lorch G; Riese DJ; Robling A; Foley J
    Mol Cancer Res; 2009 Oct; 7(10):1714-28. PubMed ID: 19825997
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential expression of the RANKL/RANK/OPG system is associated with bone metastasis in human non-small cell lung cancer.
    Peng X; Guo W; Ren T; Lou Z; Lu X; Zhang S; Lu Q; Sun Y
    PLoS One; 2013; 8(3):e58361. PubMed ID: 23516466
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RANKL inhibition blocks osteolytic lesions and reduces skeletal tumor burden in models of non-small-cell lung cancer bone metastases.
    Miller RE; Jones JC; Tometsko M; Blake ML; Dougall WC
    J Thorac Oncol; 2014 Mar; 9(3):345-54. PubMed ID: 24496001
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phenotype of bone metastases of non-small cell lung cancer: epidermal growth factor receptor expression and K-RAS mutational status.
    Badalian G; Barbai T; Rásó E; Derecskei K; Szendrôi M; Tímár J
    Pathol Oncol Res; 2007; 13(2):99-104. PubMed ID: 17607370
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thrombospondin enhances RANKL-dependent osteoclastogenesis and facilitates lung cancer bone metastasis.
    Wang M; Chao CC; Chen PC; Liu PI; Yang YC; Su CM; Huang WC; Tang CH
    Biochem Pharmacol; 2019 Aug; 166():23-32. PubMed ID: 31075265
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA-33a functions as a bone metastasis suppressor in lung cancer by targeting parathyroid hormone related protein.
    Kuo PL; Liao SH; Hung JY; Huang MS; Hsu YL
    Biochim Biophys Acta; 2013 Jun; 1830(6):3756-66. PubMed ID: 23458685
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-small cell lung cancer cell-derived exosomal miR-17-5p promotes osteoclast differentiation by targeting PTEN.
    Wang M; Zhao M; Guo Q; Lou J; Wang L
    Exp Cell Res; 2021 Nov; 408(1):112834. PubMed ID: 34537206
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Involvement of multiple myeloma cell-derived exosomes in osteoclast differentiation.
    Raimondi L; De Luca A; Amodio N; Manno M; Raccosta S; Taverna S; Bellavia D; Naselli F; Fontana S; Schillaci O; Giardino R; Fini M; Tassone P; Santoro A; De Leo G; Giavaresi G; Alessandro R
    Oncotarget; 2015 May; 6(15):13772-89. PubMed ID: 25944696
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Receptor activator of nuclear factor kappaB ligand (RANKL) is a key molecule of osteoclast formation for bone metastasis in a newly developed model of human neuroblastoma.
    Michigami T; Ihara-Watanabe M; Yamazaki M; Ozono K
    Cancer Res; 2001 Feb; 61(4):1637-44. PubMed ID: 11245477
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gut-derived serotonin induced by depression promotes breast cancer bone metastasis through the RUNX2/PTHrP/RANKL pathway in mice.
    Zong JC; Wang X; Zhou X; Wang C; Chen L; Yin LJ; He BC; Deng ZL
    Oncol Rep; 2016 Feb; 35(2):739-48. PubMed ID: 26573960
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Breast cancer exosomes contribute to pre-metastatic niche formation and promote bone metastasis of tumor cells.
    Yuan X; Qian N; Ling S; Li Y; Sun W; Li J; Du R; Zhong G; Liu C; Yu G; Cao D; Liu Z; Wang Y; Qi Z; Yao Y; Wang F; Liu J; Hao S; Jin X; Zhao Y; Xue J; Zhao D; Gao X; Liang S; Li Y; Song J; Yu S; Li Y
    Theranostics; 2021; 11(3):1429-1445. PubMed ID: 33391543
    [No Abstract]   [Full Text] [Related]  

  • 16. Amphiregulin enhances intercellular adhesion molecule-1 expression and promotes tumor metastasis in human osteosarcoma.
    Liu JF; Tsao YT; Hou CH
    Oncotarget; 2015 Dec; 6(38):40880-95. PubMed ID: 26503469
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ID1 facilitates the growth and metastasis of non-small cell lung cancer in response to nicotinic acetylcholine receptor and epidermal growth factor receptor signaling.
    Pillai S; Rizwani W; Li X; Rawal B; Nair S; Schell MJ; Bepler G; Haura E; Coppola D; Chellappan S
    Mol Cell Biol; 2011 Jul; 31(14):3052-67. PubMed ID: 21606196
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SOSTDC1 inhibits bone metastasis in non-small cell lung cancer and may serve as a clinical therapeutic target.
    Chen G; Gong H; Wang T; Wang J; Han Z; Bai G; Han S; Yang X; Zhou W; Liu T; Xiao J
    Int J Mol Med; 2018 Dec; 42(6):3424-3436. PubMed ID: 30320379
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum long non coding RNA MALAT-1 protected by exosomes is up-regulated and promotes cell proliferation and migration in non-small cell lung cancer.
    Zhang R; Xia Y; Wang Z; Zheng J; Chen Y; Li X; Wang Y; Ming H
    Biochem Biophys Res Commun; 2017 Aug; 490(2):406-414. PubMed ID: 28623135
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mixed metastatic lung cancer lesions in bone are inhibited by noggin overexpression and Rank:Fc administration.
    Feeley BT; Liu NQ; Conduah AH; Krenek L; Roth K; Dougall WC; Huard J; Dubinett S; Lieberman JR
    J Bone Miner Res; 2006 Oct; 21(10):1571-80. PubMed ID: 16995812
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.